Literature DB >> 20231860

Polyglutamine toxicity in non-neuronal cells.

Jennifer W Bradford1, Shihua Li, Xiao-Jiang Li.   

Abstract

The neurodegenerative polyglutamine diseases are caused by an expansion of unstable polyglutamine repeats in various disease proteins. Although these mutant proteins are expressed ubiquitously in neuronal and non-neuronal cells, they cause selective degeneration of specific neuronal populations. Recently, increasing evidence shows that polyglutamine disease proteins also affect non-neuronal cells. However, it remains unclear how the expression of polyglutamine proteins in non-neuronal cells contributes to the course of the polyglutamine diseases. Here, we discuss recent findings about the expression of mutant polyglutamine proteins in non-neuronal cells and their influence on neurological symptoms. Understanding the contribution of non-neuronal polyglutamine proteins to disease progression will help elucidate disease mechanisms and also help in the development of new treatment options.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20231860      PMCID: PMC3074229          DOI: 10.1038/cr.2010.32

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  88 in total

1.  Impaired glucose tolerance in the R6/1 transgenic mouse model of Huntington's disease.

Authors:  K Josefsen; M D Nielsen; K H Jørgensen; T Bock; A Nørremølle; S A Sørensen; B Naver; L Hasholt
Journal:  J Neuroendocrinol       Date:  2007-11-22       Impact factor: 3.627

2.  Frontotemporal cognitive function in X-linked spinal and bulbar muscular atrophy (SBMA): a controlled neuropsychological study of 20 patients.

Authors:  Georg Rüdiger Soukup; Anne-Dorte Sperfeld; Ingo Uttner; Jochen Karitzky; Albert Christian Ludolph; Jan Kassubek; Herbert Schreiber
Journal:  J Neurol       Date:  2009-07-02       Impact factor: 4.849

Review 3.  Reactive astrocytes: cellular and molecular cues to biological function.

Authors:  J L Ridet; S K Malhotra; A Privat; F H Gage
Journal:  Trends Neurosci       Date:  1997-12       Impact factor: 13.837

4.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

Authors:  M DiFiglia; E Sapp; K O Chase; S W Davies; G P Bates; J P Vonsattel; N Aronin
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

5.  Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration.

Authors:  Patrick Weydt; Victor V Pineda; Anne E Torrence; Randell T Libby; Terrence F Satterfield; Eduardo R Lazarowski; Merle L Gilbert; Gregory J Morton; Theodor K Bammler; Andrew D Strand; Libin Cui; Richard P Beyer; Courtney N Easley; Annette C Smith; Dimitri Krainc; Serge Luquet; Ian R Sweet; Michael W Schwartz; Albert R La Spada
Journal:  Cell Metab       Date:  2006-10-19       Impact factor: 27.287

6.  GFAP Transgenic Mice

Authors: 
Journal:  Methods       Date:  1996-12       Impact factor: 3.608

7.  Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington's disease mutation.

Authors:  Richard R Ribchester; Derek Thomson; Nigel I Wood; Tim Hinks; Thomas H Gillingwater; Thomas M Wishart; Felipe A Court; A Jennifer Morton
Journal:  Eur J Neurosci       Date:  2004-12       Impact factor: 3.386

8.  Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease.

Authors:  Cheryl L Wellington; Lisa M Ellerby; Claire-Anne Gutekunst; Danny Rogers; Simon Warby; Rona K Graham; Odell Loubser; Jeremy van Raamsdonk; Roshni Singaraja; Yu-Zhou Yang; Juliette Gafni; Dale Bredesen; Steven M Hersch; Blair R Leavitt; Sophie Roy; Donald W Nicholson; Michael R Hayden
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

9.  Protein misfolding and cardiac disease: establishing cause and effect.

Authors:  J Scott Pattison; Jeffrey Robbins
Journal:  Autophagy       Date:  2008-06-26       Impact factor: 16.016

10.  Cardiomyocyte expression of a polyglutamine preamyloid oligomer causes heart failure.

Authors:  J Scott Pattison; Atsushi Sanbe; Alina Maloyan; Hanna Osinska; Raisa Klevitsky; Jeffrey Robbins
Journal:  Circulation       Date:  2008-05-19       Impact factor: 29.690

View more
  13 in total

1.  Neuronal expression of TATA box-binding protein containing expanded polyglutamine in knock-in mice reduces chaperone protein response by impairing the function of nuclear factor-Y transcription factor.

Authors:  Shanshan Huang; Joseph J Ling; Su Yang; Xiao-Jiang Li; Shihua Li
Journal:  Brain       Date:  2011-07       Impact factor: 13.501

2.  Dictyostelium discoideum has a highly Q/N-rich proteome and shows an unusual resilience to protein aggregation.

Authors:  Liliana Malinovska; Sandra Palm; Kimberley Gibson; Jean-Marc Verbavatz; Simon Alberti
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-04       Impact factor: 11.205

3.  Progressive cardiac arrhythmias and ECG abnormalities in the Huntington's disease BACHD mouse model.

Authors:  Yujie Zhu; Isaac Shamblin; Efrain Rodriguez; Grace E Salzer; Lita Araysi; Katherine A Margolies; Ganesh V Halade; Silvio H Litovsky; Steven Pogwizd; Michelle Gray; Sabine Huke
Journal:  Hum Mol Genet       Date:  2020-02-01       Impact factor: 6.150

4.  Effects of flanking sequences and cellular context on subcellular behavior and pathology of mutant HTT.

Authors:  Anjalika Chongtham; Douglas J Bornemann; Brett A Barbaro; Tamas Lukacsovich; Namita Agrawal; Adeela Syed; Shane Worthge; Judith Purcell; John Burke; Theodore M Chin; J Lawrence Marsh
Journal:  Hum Mol Genet       Date:  2020-03-13       Impact factor: 6.150

5.  Huntington's Disease-Induced Cardiac Disorders Affect Multiple Cellular Pathways.

Authors:  Girish C Melkani
Journal:  React Oxyg Species (Apex)       Date:  2016-09

Review 6.  The role of the immune system in triplet repeat expansion diseases.

Authors:  Marta Olejniczak; Martyna O Urbanek; Wlodzimierz J Krzyzosiak
Journal:  Mediators Inflamm       Date:  2015-03-22       Impact factor: 4.711

Review 7.  Oligonucleotide-based strategies to combat polyglutamine diseases.

Authors:  Agnieszka Fiszer; Wlodzimierz J Krzyzosiak
Journal:  Nucleic Acids Res       Date:  2014-05-21       Impact factor: 16.971

8.  Antisense oligonucleotide-mediated exon skipping as a strategy to reduce proteolytic cleavage of ataxin-3.

Authors:  Lodewijk J A Toonen; Iris Schmidt; Martijn S Luijsterburg; Haico van Attikum; Willeke M C van Roon-Mom
Journal:  Sci Rep       Date:  2016-10-12       Impact factor: 4.379

9.  Huntington's disease induced cardiac amyloidosis is reversed by modulating protein folding and oxidative stress pathways in the Drosophila heart.

Authors:  Girish C Melkani; Adriana S Trujillo; Raul Ramos; Rolf Bodmer; Sanford I Bernstein; Karen Ocorr
Journal:  PLoS Genet       Date:  2013-12-19       Impact factor: 5.917

10.  Drosophila as a potential model to ameliorate mutant Huntington-mediated cardiac amyloidosis.

Authors:  Adriana S Trujillo; Raul Ramos; Rolf Bodmer; Sanford I Bernstein; Karen Ocorr; Girish C Melkani
Journal:  Rare Dis       Date:  2014-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.